The new EFPIA Disclosure Code – Is the Need for Transparency Outweighing Data Privacy Compliance?

John Giannakakis, Regional Counsel Southern Europe , Novartis Hellas SACI, Greece

European Federation of Pharmaceutical Industries and Associations (EFPIA) adopted on 24 June 2013, the EFPIA Disclosure Code, that is a code of conduct which obliges its member companies, from 2016, onwards, to make public the details of payments and transfers of value made to healthcare professionals (HCPs) and healthcare organizations (HCOs). The first disclosures will be made in June 2016 and will concern information about Transfers of Value ( ToV) made in 2015. In order to help its Members to be prepared for that obligation, EFPIA has launched a new website: --“”—aiming to highlight the new disclosure rules, follow best practices in the implementation of the Disclosure Code and monitor compliance in the 33 countries involved in the initiative (i.e. the 28 EU member states, plus Switzerland, Russia, Ukraine, Turkey and Serbia).

Read full paper Subscribe to the IICJ
Greece Corporate Governance Pharmaceutical February 2016 Vol. 9, No. 34, Winter 2016

John Giannakakis


John Giannakakis has a 25 year experience as Corporate Counsel and freelance litigator in different and challenging industries i.e. Insurance, Real Estate, Consumer Goods, Pharmaceuticals and Security & Investigations. John holds a BSc in Law from the U

Novartis Hellas SACI


. G4S is the world’s leading international security solutions group, which specialises in secure outsourcing in countries and sectors where security and safety risks are considered a strategic threat. We make a difference by helping people to operat

Greece Corporate Governance Pharmaceutical February 2016 Vol. 9, No. 34, Winter 2016

© International In-House Counsel Journal. ISSN 1754-0607. All rights reserved. Registered in England Company Number: 6187841. VAT Registration Number: 946 7381 82. | Terms & Conditions .